Almirall

Almirall is a pharmaceutical company based in Barcelona, Spain, founded in 1944. It operates in over 19 countries and has partnerships in more than 100 countries worldwide. The company specializes in medical dermatology, developing prescription drugs for various skin conditions, including psoriasis, atopic dermatitis, acne, and rosacea. The core business of Almirall includes research, development, production, and marketing of innovative dermatological treatments. It employs a range of technologies, including small molecules and biologics, to address unmet medical needs. Key marketed brands include Ilumetri, Wynzora, and Skilarence. Almirall has expanded its portfolio through acquisitions, enhancing its capabilities in dermatology. With a strong commitment to innovation, Almirall aims to be a global leader in skincare. The company emphasizes sustainability and societal contributions, integrating these values into its operations. Its products are primarily prescribed by dermatologists and healthcare professionals, supported by a robust global commercial and R&D infrastructure.